Insider transactions

EDGAR

SCIENTIFIC INDUSTRIES, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-18.

Open-market purchases (code P)
11 transactions, 140,200 shares
Sum of shares × price per share: 88,419.54
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–20 of 20

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-05 Filed 2026-11-05MOORE JOHN A Director · Officer: Chairman of the Board
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)10,0000.6
6,000

Derived: shares × price per share. Exact value 6000.0.

1,018,941Direct (D) No— Open filing 0001182944-26-000009 Read from the filing’s XML Dispute this row
2026-10-31 Filed 2026-11-05MOORE JOHN A Director · Officer: Chairman of the Board
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)7,1000.6
4,260

Derived: shares × price per share. Exact value 4260.0.

1,008,941Direct (D) No— Open filing 0001182944-26-000008 Read from the filing’s XML Dispute this row
2026-10-31 Filed 2026-11-05MOORE JOHN A Director · Officer: Chairman of the Board
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)51,2000.65
33,280

Derived: shares × price per share. Exact value 33280.00.

1,001,841Direct (D) No— Open filing 0001182944-26-000007 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-09-08MOORE JOHN A Director · Officer: Chairman of the Board
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,0000.76
3,800

Derived: shares × price per share. Exact value 3800.00.

950,641Direct (D) No— Open filing 0001182944-26-000006 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-20MOORE JOHN A Director · Officer: Chairman of the Board
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)14,7000.7112
10,454.64

Derived: shares × price per share. Exact value 10454.6400.

945,641Direct (D) No— Open filing 0001182944-26-000005 Read from the filing’s XML Dispute this row
2026-06-02 Filed 2026-06-18MOORE JOHN A Director · Officer: Chairman of the Board
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)4,0000.7113
2,845.2

Derived: shares × price per share. Exact value 2845.2000.

930,871Direct (D) No— Open filing 0001182944-26-000004 Read from the filing’s XML Dispute this row
2026-03-23 Filed 2026-03-24MOORE JOHN A Director · Officer: Chairman
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)9,0000.58
5,220

Derived: shares × price per share. Exact value 5220.00.

926,871Direct (D) No— Open filing 0001182944-26-000003 Read from the filing’s XML Dispute this row
2026-02-19 Filed 2026-03-17MOORE JOHN A Director · Officer: Chairman of the Board
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)1,0000.65
650

Derived: shares × price per share. Exact value 650.00.

917,871Direct (D) No— Open filing 0001182944-26-000002 Read from the filing’s XML Dispute this row
2026-02-17 Filed 2026-04-01SANTOS HELENA R Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option — underlying Common Stock (50,000) — exercise price 0.6
Acquired (A)50,000——433,388Direct (D) No
F1
  • F1 Options granted to Registrant in lieu of salary. Vesting 1 year - 1/12th per month.
Open filing 0001286205-26-000003 Read from the filing’s XML Dispute this row
2026-02-17 Filed 2026-04-01SANTOS HELENA R Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option — underlying Common Stock (130,000) — exercise price 0.6
Acquired (A)130,0000—563,388Direct (D) No
F1
  • F1 Vesting is based on 4 year cliff from date of option grant.
Open filing 0001286205-26-000004 Read from the filing’s XML Dispute this row
2026-02-17 Filed 2026-03-17MOORE JOHN A Director · Officer: Chairman of the Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option — underlying Common Stock (230,000) — exercise price 0.6
Acquired (A)230,0000—886,871Direct (D) No
F1
  • F1 Options granted to Registrant in lieu of cash compensation. Vesting is 1 year - 1/12th per month.
Open filing 0001182944-26-000001 Read from the filing’s XML Dispute this row
2026-02-17 Filed 2026-03-17MOORE JOHN A Director · Officer: Chairman of the Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option — underlying Common Stock (30,000) — exercise price 0.6
Acquired (A)30,0000—916,871Direct (D) No— Open filing 0001182944-26-000001 Read from the filing’s XML Dispute this row
2026-02-17 Filed 2026-03-17BLECHMAN MICHAEL Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option — underlying Common Stock (24,000) — exercise price 0.6
Acquired (A)24,0000—96,186Direct (D) No
F1
  • F1 Options granted to Registrant in lieu of cash fees. Vesting 1 year - 1/12th per month.
Open filing 0002021300-26-000001 Read from the filing’s XML Dispute this row
2026-02-17 Filed 2026-03-17BLECHMAN MICHAEL Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option — underlying Common Stock (20,000) — exercise price 0.6
Acquired (A)20,0000—116,186Direct (D) No— Open filing 0002021300-26-000001 Read from the filing’s XML Dispute this row
2026-02-17 Filed 2026-03-17Rovinsky Zachary Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option — underlying Common Stock (25,000) — exercise price 0.6
Acquired (A)25,0000—45,000Direct (D) No
F1
  • F1 Vesting is based on 4 year cliff from date of option grant.
Open filing 0002092274-26-000003 Read from the filing’s XML Dispute this row
2026-02-17 Filed 2026-03-17NICOLS JOHN J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option — underlying Common Stock (120,000) — exercise price 0.6
Acquired (A)120,0000—255,778Direct (D) No
F1
  • F1 On 2/17/26 Registrant was awarded stock options in lieu of cash fees. Vesting 1 Year - 1/12th per month.
Open filing 0001238884-26-000001 Read from the filing’s XML Dispute this row
2026-02-17 Filed 2026-03-17NICOLS JOHN J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option — underlying Common Stock (20,000) — exercise price 0.6
Acquired (A)20,0000—275,778Direct (D) No
F1
  • F1 On 2/17/26 Registrant was awarded stock options in lieu of cash fees. Vesting 1 Year - 1/12th per month.
Open filing 0001238884-26-000001 Read from the filing’s XML Dispute this row
2025-12-17 Filed 2025-12-18MOORE JOHN A Director · Officer: Chairman
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)6,5000.5315
3,454.75

Derived: shares × price per share. Exact value 3454.7500.

663,371Direct (D) No— Open filing 0001182944-25-000009 Read from the filing’s XML Dispute this row
2025-12-17 Filed 2025-12-18MOORE JOHN A Director · Officer: Chairman
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)11,7000.5435
6,358.95

Derived: shares × price per share. Exact value 6358.9500.

656,871Direct (D) No— Open filing 0001182944-25-000008 Read from the filing’s XML Dispute this row
2025-12-05 Filed 2025-12-15MOORE JOHN A Director · Officer: Chairman
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)20,0000.6048
12,096

Derived: shares × price per share. Exact value 12096.0000.

645,171Direct (D) No— Open filing 0001182944-25-000007 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
LYTTON LAURENCE W Common Stock9.991,226,104.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000935836-26-000394 Dispute this row
Lytton-Kambara Foundation Common Stock9.91,245,527.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000935836-26-000394 Dispute this row
Bleichroeder LP Common Stock, $0.05 par value21.192,715,02609/30/2025 Filed 2025-11-14SCHEDULE 13D/AAmendment 4Open filing 0001420506-25-003305 Dispute this row
Bleichroeder Holdings LLC Common Stock, $0.05 par value21.192,715,02609/30/2025 Filed 2025-11-14SCHEDULE 13D/AAmendment 4Open filing 0001420506-25-003305 Dispute this row
Andrew Gundlach Common Stock, $0.05 par value21.192,715,02609/30/2025 Filed 2025-11-14SCHEDULE 13D/AAmendment 4Open filing 0001420506-25-003305 Dispute this row
North Run Capital, LP Common Stock, par value $0.05 per share9.991,189,63209/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 4Open filing 0001193125-25-279174 Dispute this row
North Run Advisors, LLC Common Stock, par value $0.05 per share9.991,189,63209/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 4Open filing 0001193125-25-279174 Dispute this row
Todd B. Hammer Common Stock, par value $0.05 per share9.991,189,63209/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 4Open filing 0001193125-25-279174 Dispute this row
Thomas B. Ellis Common Stock, par value $0.05 per share9.991,189,63209/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 4Open filing 0001193125-25-279174 Dispute this row
Michael Bosco Common Stock, par value $0.05 per share9.991,189,63209/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 4Open filing 0001193125-25-279174 Dispute this row
North Run - Due North Partners, LP Common Stock, par value $0.05 per share9.991,189,63209/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 4Open filing 0001193125-25-279174 Dispute this row
North Run GP, LP Common Stock, par value $0.05 per share9.991,189,63209/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 4Open filing 0001193125-25-279174 Dispute this row
Brian L. Pessin Common stock, par value $0.05 per share3.3397,53108/21/2025 Filed 2025-08-22SCHEDULE 13D/AAmendment 3Open filing 0001140361-25-032306 Dispute this row
Norman H. Pessin Common stock, par value $0.05 per share4.7570,00008/21/2025 Filed 2025-08-22SCHEDULE 13D/AAmendment 3Open filing 0001140361-25-032306 Dispute this row
PESSIN SANDRA F Common stock, par value $0.05 per share3.9466,50708/21/2025 Filed 2025-08-22SCHEDULE 13D/AAmendment 3Open filing 0001140361-25-032306 Dispute this row
North Run Capital, LP Common Stock, par value $0.05 per share9.991,189,63206/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 3Open filing 0000950170-25-107640 Dispute this row
North Run Advisors, LLC Common Stock, par value $0.05 per share9.991,189,63206/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 3Open filing 0000950170-25-107640 Dispute this row
Todd B. Hammer Common Stock, par value $0.05 per share9.991,189,63206/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 3Open filing 0000950170-25-107640 Dispute this row
Thomas B. Ellis Common Stock, par value $0.05 per share9.991,189,63206/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 3Open filing 0000950170-25-107640 Dispute this row
Michael Bosco Common Stock, par value $0.05 per share9.991,189,63206/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 3Open filing 0000950170-25-107640 Dispute this row
North Run - Due North Partners, LP Common Stock, par value $0.05 per share9.991,189,63206/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 3Open filing 0000950170-25-107640 Dispute this row
North Run GP, LP Common Stock, par value $0.05 per share9.991,189,63206/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 3Open filing 0000950170-25-107640 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,282,907 filings read, dated 2004-06-14 to 2026-11-17: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20152,524
2016204,322
2017203,709
2018202,770
2019208,469
2020144,184
2021224,474
2022158,941
2023199,811
2024209,823
2025235,520
2026260,174

Filings made before the SEC required XML are listed, not extracted.

Back to SCIENTIFIC INDUSTRIES, INC.